All data are based on the daily closing price as of June 27, 2025
e
Eiken Chemical
4549.TSE
14.77 USD
0.08
+0.54%
Overview
Last close
14.77 usd
Market cap
485.03M usd
52 week high
17.03 usd
52 week low
11.50 usd
Target price
15.9 usd
Valuation
P/E
33.2243
Forward P/E
N/A
Price/Sales
1.7275
Price/Book Value
1.6064
Enterprise Value
444.14M usd
EV/Revenue
1.5849
EV/EBITDA
11.5514
Key financials
Revenue TTM
280.24M usd
Gross Profit TTM
114.14M usd
EBITDA TTM
36.54M usd
Earnings per Share
0.44 usd
Dividend
0.37 usd
Total assets
418.35M usd
Net debt
-21.29M usd
About
Eiken Chemical Co., Ltd., together with its subsidiaries, engages in the manufacturing and sale of clinical diagnostics in Japan. It offers microbiological reagents for diagnosis of microorganism infection, such as mediums, antimicrobial susceptibility, and rapid test reagents; urinalysis test strips for occult blood, protein, and glucose; and fecal immunochemical tests reagents for screening of colorectal cancer. The company also provides immunological and serological reagents to detect and monitor infectious disease, rheumatism, inflammation, atrophic gastritis, and prostate specific antigens; and clinical chemistry tests to measure and analyze biological components in blood serum and urine. In addition, it sells reagents and devices of microbiological test for food poisoning bacteria and environmental inspection; and offers nucleic acid amplification method, as well as provides various types of automated analyzers. Its product portfolio includes fecal testing OC-sensor, molevular test LAMP, immunological and serological reagent LS test Eiken, and veterinary VET-SAA Eiken. The company was formerly known as Nihon Eiyokagaku Co., Ltd. and changed its name to Eiken Chemical Co., Ltd. in 1969. Eiken Chemical Co., Ltd. was incorporated in 1939 and is headquartered in Tokyo, Japan.